The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling.

Autor: Marr AR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Halpin M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Corbin DL; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Asemelash Y; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sher S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Gordon BK; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Whipp EC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Mitchell S; Department of Pathology, Stanford University, Stanford, CA, USA., Harrington BK; College of Veterinary Medicine, Michigan State University, Lansing, MI, USA., Orwick S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Benrashid S; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Goettl VM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Yildiz V; Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA., Mitchell AD; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Cahn O; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Mims AS; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Larkin KTM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Long M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Blachly J; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Leukemia Research Program, The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA., Woyach JA; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Leukemia Research Program, The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA., Lapalombella R; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.; Leukemia Research Program, The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA., Grieselhuber NR; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. Nicole.Grieselhuber@osumc.edu.; Leukemia Research Program, The Ohio State University James Comprehensive Cancer Center, Columbus, OH, USA. Nicole.Grieselhuber@osumc.edu.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2024 Mar 04; Vol. 13 (1), pp. 27. Date of Electronic Publication: 2024 Mar 04.

What is the role of leukopenia in the assessment of septic arthritis?

Autor: Brown CR; Department of Orthopaedics, The Ohio State University Wexner Medical Center, USA., Samade R; Department of Orthopaedics, The Ohio State University Wexner Medical Center, USA., Lynch D; College of Medicine, The Ohio State University Wexner Medical Center, USA., Mickley J; College of Medicine, The Ohio State University Wexner Medical Center, USA., Larkin KTM; Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, USA., Speeckaert AL; Department of Orthopaedics, The Ohio State University Wexner Medical Center, USA.

Publikováno v: Journal of orthopaedics [J Orthop] 2022 May 07; Vol. 32, pp. 13-17. Date of Electronic Publication: 2022 May 07 (Print Publication: 2022).

Assessment for Septic Arthritis in Immunocompetent and Immunocompromised Patients: A Single-Institution Study.

Autor: Brown CR; From the Department of Orthopaedic Surgery (Brown, Samade, and Speeckaert), The Ohio State University Wexner Medical Center, the College of Medicine (Turnquist, Mickley, and Lynch), The Ohio State University Wexner Medical Center, and the Division of Hematology (Larkin), Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH., Samade R, Turnquist E, Mickley J, Lynch D, Larkin KTM, Speeckaert AL

Publikováno v: The Journal of the American Academy of Orthopaedic Surgeons [J Am Acad Orthop Surg] 2022 Jan 01; Vol. 30 (1), pp. 27-35.

Inhibiting the Inhibitors of Apoptosis: When Two Targets Are Better Than One.

Autor: Larkin KTM; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Byrd JC; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. John.Byrd@osumc.edu john.byrd@ucmail.uc.edu.

Publikováno v: Cancer discovery [Cancer Discov] 2021 Jun; Vol. 11 (6), pp. 1324-1326.